These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3791258)

  • 21. Vindesine in the treatment of malignant mesothelioma: a phase II study.
    Kelsen D; Gralla R; Cheng E; Martini N
    Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
    Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotherapy of recurrent/advanced cervical cancer: results of the Yale University PBM-PFU protocol.
    Chambers SK; Lamb L; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1994 May; 53(2):161-9. PubMed ID: 7514557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysis.
    Klaassen U; Wilke H; Pari CP; Strumberg D; Harstrick A; Eberhardt W; Becher R; Diergarten K; Seeber S
    Semin Oncol; 1995 Dec; 22(6 Suppl 14):7-11. PubMed ID: 8553083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma.
    Tiersten AD; Selleck MJ; Hershman DL; Smith D; Resnik EE; Troxel AB; Brafman LB; Shriberg L
    Gynecol Oncol; 2004 Feb; 92(2):635-8. PubMed ID: 14766258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First-line chemotherapy with 5-FU and platinum for advanced and recurrent cancer of the cervix: a phase II study.
    Ghaemmaghami F; Behtash N; Yarandi F; Moosavi A; Modares M; Toogeh G; Khanafshar N
    J Obstet Gynaecol; 2003 Jul; 23(4):422-5. PubMed ID: 12881087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Rose PG; Blessing JA; Arseneau J
    Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS; Blessing JA; Boike G
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of continuous vindesine administration of advanced breast cancer resistant to chemotherapy including adriamycin.
    Adachi I; Watanabe T; Suzuki M; Tsuchihashi T; Yin DF; Yamaguchi K; Abe K
    Jpn J Clin Oncol; 1991 Jun; 21(3):180-7. PubMed ID: 1942549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.
    Tinker AV; Bhagat K; Swenerton KD; Hoskins PJ
    Gynecol Oncol; 2005 Jul; 98(1):54-8. PubMed ID: 15904950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vindesine. A phase II trial in advanced breast cancer patients.
    Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
    Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase I study of ifosfamide, paclitaxel, and carboplatin in advanced and recurrent cervical cancer.
    Downs LS; Judson PL; Argenta PA; Carson LF; Boente MP
    Gynecol Oncol; 2004 Nov; 95(2):347-51. PubMed ID: 15491756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II study of prolonged oral etoposide in advanced or recurrent carcinoma of the cervix.
    Morris M; Brader KR; Burke TW; Levenback CF; Gershenson DM
    Gynecol Oncol; 1998 Aug; 70(2):215-8. PubMed ID: 9740693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carboplatin, vindesine, 5-fluorouracil-leucovorin and 13-cis retinoic acid in the treatment of advanced non-small cell lung cancer. A phase II study.
    Recchia F; De Filippis S; Pompili PL; Rosselli M; Saggio G; Ciorra A; Piccinini M; Rea S
    Clin Ter; 1999; 150(4):269-74. PubMed ID: 10605163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
    Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
    Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medical treatment of metastatic or recurrent cancer of the cervix].
    de la Motte Rouge T; Pautier P; Hamy AS; Duvillard P; Bruna A; Castaigne D; Morice P; Haie-Meder C; Lhommé C
    Bull Cancer; 2006 Mar; 93(3):263-70. PubMed ID: 16567313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-arterial chemotherapy with cisplatin followed by radical radiotherapy for locally advanced cervical cancer.
    Sueyama H; Nakano M; Sakumoto K; Toita T; Takizawa Y; Moromizato H; Kakihana Y; Kushi A; Moromizato H; Higashi M
    Gynecol Oncol; 1995 Dec; 59(3):327-32. PubMed ID: 8522249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II study of vindesine in the treatment of esophageal carcinoma. Japanese Esophageal Oncology Group.
    Lizuka T; Kakegawa T; Ide H; Ando N; Watanabe H; Mori S; Sasaki K; Takagi I; Nashimoto A; Ishida K
    Jpn J Clin Oncol; 1989 Dec; 19(4):380-3. PubMed ID: 2607639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of vindesine in the treatment of pediatric patients with solid tumors: a report from the Childrens Cancer Study Group.
    Krailo MD; Krivit W; Sather H; Hammond D
    Cancer Treat Rep; 1986 Jun; 70(6):807-9. PubMed ID: 3524830
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.